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ABSTRACT 
Purpose: Diffusion-weighted MR imaging (DW-MRI) is generally applied to diagnose intra-axial brain pathologies such 
as parenchyma metastasis, abscesses, and infarcts in patients with systemic cancer. This study aimed to evaluate the 
DW-MRI findings in cranial bone marrow metastases to facilitate diagnosis.  
Material and Methods: Conventional MR imaging and DW-MRI findings of 57 patients with cranial bone marrow 
metastases were evaluated retrospectively. These images were evaluated by two neuroradiologists for lesion detection 
and lesion consciousness. Reader agreement was assessed by κ statistics. 
Results: Fifty-seven patients exhibited 113 cranial bone marrow metastases. The sensitivities of DW-MRI and the 
apparent diffusion coefficient to detect cranial bone metastasis for all types of primary malignancy were 86% and 90%, 
respectively. The sensitivities of T1-weighted imaging (T1WI), fluid attenuation inversion recovery, contrast-enhanced 
fat-suppressed (CE-FS) T1WI, and T2WI sequences to detect cranial bone metastasis were 93%, 90%, 89%, and 84%, 
respectively. Regarding lesion conspicuousness, DW-MRI was equivalent to CE-FS T1WI and equivalent or superior to 
non-contrast conventional sequences in most of the cranial bone marrow metastases.  Interobserver agreement was 
excellent. 
Conclusions: DW-MRI is generally indicated not only to assess the diagnosis of parenchyma involvement, but also to 
discover the cranial bone marrow metastasis in patients with systemic cancer. 
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ÖZET 
Amaç: Difüzyon ağırlıklı MR (DAG-MR) görüntüleme genellikle sistemik kanserli hastalarda parankim metastazı, abse 
ve infart gibi intraaksiyel beyin patolojilerinin tanısında kullanılmaktadır. Bu çalışmada DAG –MR’nin kranial kemik iliği 
metastazlarının tanısındaki değeri araştırılmıştır. 
Materyal ve Metod: Kranial kemik iliği metastazı saptanan 57 hastanın konvansiyonel MR ve DAG-MR görüntüleri 
geriye dönük olarak değerlendirildi. Görüntüler 2 nöroradyolog tarafından lezyon saptanması ve göze çarpıcılığı 
açısından incelendi. Radyologların kappa uyumuna bakıldı. 
Bulgular: Elli yedi hastada toplam 113 kranial kemik iliği metastazı saptandı. DAG-MR ve ADC’ nin lezyon saptama 
sensitivitesi sırasıyla %86 and %90 saptandı.T1, FLAIR, kontrastlı yağ baskılamalı T1 ve T2 ağırlıklı sekansların lezyon 
saptanmasında sensitivitesi sırasıyla %93, %90, % 89, ve %84 saptandı. DAG-MR’nin lezyon göze çarpıcılığı kontrastlı 
T1 ağırlıklı görüntülere eşit, diğer konvansiyonel sekanslara eşit ya da üstündü. Radyologların kappa uyumu 
mükemmeldi. 
Sonuç: DAG-MR sadece parankim tutulumunu değerlendirme değil, kemik iliği metastazlarını da değerlendirmede 
kullanılabilir 
Anahtar kelimeler: Kraniyal kemik iliği, metastaz, Beyin MR, Difüzyon MR 
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INTRODUCTION 
 Neurologic complications occur frequently in 
patients with systemic cancer. Brain metastases 
are the most common neurologic complication of 
systemic cancer in adult patients. Indirect effects of 
systemic cancer include vascular disorders, 
infections, metabolic abnormalities and 
paraneoplastic syndromes
1
. MR imaging plays a 
major role in the evaluation and management of 
patients with metastatic brain tumors. Although 
conventional MR imaging remains an excellent 
screening tool, diffusion-weighted MR imaging 
(DW-MRI) is more sensitive for detecting 
neurologic complications
2
. DW-MRI is applied for 
the diagnosis of parenchyma metastasis, 
abscesses, and infarcts in patients with systemic 
cancer, in addition to routine conventional 
sequences in most radiology centers.  
 Cranial bone marrow metastasis occurs most 
frequently in carcinomas of the breast, lung, 
prostate, and kidney in adults; however, in 
pediatric patients, neuroblastoma and sarcoma are 
observed more frequently. The best imaging 
modality to evaluate bone marrow is MR imaging 
due to its high resolution
3
. Normal fatty bone 
marrow in the adult population is hyperintense on 
T1-weighted images. Cranial bone marrow 
metastases may be easily detected on T1-
weighted images because they appear as 
hypointense lesions. On contrast-enhanced, non-
fat-saturated sequences, they may be obscured by 
bone marrow signals. Contrast-enhanced fat-
saturated (CE-FS) MR imagings are superior for 
detecting bone marrow lesions and involvement of 
the adjacent dura or brain
2
. However, for the 
inexperienced reader, cranial bone marrow 
metastasis may be overlooked on routine, 
conventional MRI examination. 
 Although DW-MRI is a well-known diagnostic 
tool for evaluation of central nervous system 
diseases, it has had limited use in cranial bone 
marrow pathologies. On DW-MRI, the background  
 
normal skull is markedly hypointense: the 
intradiploic fat is hypointense because echo-planar 
sequences are typically obtained with fat 
suppression. Increased tumor cell packing may 
lead to a smaller and more restricted extracellular 
space. This decreased amount of free water, as 
well as its restricted mobility due to hypercellularity, 
may result in increased signal intensity on DW-
MRI
4
. We investigated the role of DW-MRI in the 
assessment of cranial bone marrow metastasis 
and compared DW-MRI with conventional MRI.  
MATERIALS and METHODS 
Patients  
 Institutional review board approval was 
obtained for the present retrospective study. A 
database search was performed to identify all 
patients with cranial bone marrow metastases 
among those who underwent imaging at our 
institution between January 2010 and April 2014. 
Fifty-seven patients (27 females and 30 males) 
with an age range of 2–89 years (mean age, 55.7 
years) were identified. These patients were 
referred for MR imaging of known or clinically 
suspected intracranial metastases with primary 
neoplasm. Diagnoses of bone marrow metastasis 
were made based on biopsy findings, bone 
scintigraphy, positron emission tomography (PET) 
or follow-up MRI.  Twenty patients had undergone 
bone scintigraphy, and 15 of them had abnormal 
uptake on bone scintigraphy. Fourteen patients 
had undergone PET, and six of them showed 
abnormal uptake. Histological verification was 
obtained in four patients. For remaining patients, 
the diagnosis was confirmed at the follow up by 
MR imaging. Primary neoplasms included breast 
cancer (n=15), lung cancer (n=13), prostate cancer 
(n=10), renal cell carcinoma (n=3), nasopharynx 
cancer (n=2), neuroblastoma (n=2), 
neuroendocrine tumor (n=2), adrenocortical 
carcinoma (n=1), cholangiocellular carcinoma 
(n=2), urinary bladder cancer (n=2), cervix cancer 
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(n=1), ovarian cancer (n=1), thyroid cancer (n=1), 
primitive neuroectodermal tumor (n=1), and 
squamous cell carcinoma of the neck (n=1).   
 
Imaging Parameters 
 Brain MRI was performed in all patients using 
a 1.5-Tesla MR scanner (Magnetom Avanto or 
Symphony; Siemens Medical Solutions, Erlangen, 
Germany). All of the sequences were performed 
using identical parameters for the number of slices, 
matrix size (256 × 256), field of view (230 mm), 
slice thickness (5 mm) and intersection gap (1.5 
mm). Sagittal and axial T1-weighted spin echo 
(SE) images (repetition Time (TR)/echo time 
(TE)/number of excitations (NEX): 500 ms/11 ms/2, 
respectively), coronal and axial T2-weighted turbo 
SE images (TR/TE/NEX: 4500 ms/110 ms/2, 
respectively), axial fluid attenuation inversion 
recovery (FLAIR) images (TR/TE/NEX: 9000 
ms/110 ms/2, respectively), axial contrast-
enhanced fat-suppressed T1-weighted imaging 
with gadolinium (CE-FS T1WI) with SE, and 
coronal and sagittal T1-weighted SE images with 
gadolinium (TR/TE/NEX: 429 ms/12 ms/2, 
respectively) were acquired as part of the routine 
imaging protocol. All of the patients underwent 
DW-MRI in the transverse plane, using a single-
shot, SE echo-planar readout. Diffusion-sensitizing 
gradients were applied in three orthogonal 
directions with diffusion sensitivities of b = 0 and 
1000 s/mm² (TR/TE/NEX: 4200 ms/115 ms/2, 
respectively). Apparent diffusion coefficient (ADC) 
maps were generated using commercially available 
software.  
 
Image Assessment 
 Two independent experienced 
neuroradiologists (O.A. and N.A. with 12 and 6 
years of experience in interpreting head and neck 
MR images, respectively) blinded to the clinical 
histories of the patients and diagnoses reviewed 
the MR images, including conventional MR images 
and DW-MR images (trace and ADC images). The 
number, location, size and involvement type 
(focal/diffuse) of calvarial lesions, and the 
presence of dural, scalp and parenchymal 
metastases were assessed. The signal intensity of 
the lesions was categorized as hypointense, 
isointense, or hyperintense with respect to the 
presumed normal marrow. Enhancement of the 
lesions was evaluated on CE-FS T1WI. 
Conventional MRI and DW-MRI were read as 
positive for hypointense and hyperintense images 
and negative for isointense images. In the first 
reading session, the two readers assessed 
independently the images in terms of lesion 
conspicuousness. The images were compared 
side by side to determine which sequence was 
better in terms of the conspicuousness of lesions 
from adjacent structures. Comparison between 
DW-MRI and routine sequences was performed 
only for the axial images. We used a combination 
of trace and ADC images for lesion 
conspicuousness. Lesion conspicuousness was 
classified as superior to DW-MRI, equivalent to 
DW-MRI or inferior to DW-MRI. At the consensus 
reading, the lesion conspicuousness and detection 
were determined to form a standard of reference.  
 
Statistical Analysis 
 Statistical analysis was performed using the 
statistical software package SPSS (version 17.0; 
SPSS Inc., Chicago, IL, USA). The categorical 
variables were analyzed using chi-squared test or 
Fisher’s exact test. Interobserver reliability was 
applied using Cronbach’s alpha reliability value. 
Correlations between observers were tested using 
the intra-rater correlation test. A p value of 0.05 
was deemed to indicate statistical significance. 
The diagnoses made by the reviewers were 
characterized as true positive, false negative, or 
false positive. For each imaging modality, the 
sensitivity was calculated using the following 
equation: sensitivity (%) = [number of true 
positives/ (true positives + false negatives)] ×100. 
Specificity could not be calculated because the 
true negatives could not be accurately defined.  
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RESULTS 
 One hundred and thirteen lesions were 
detected in 57 patients: six lesions (5.3%) showed 
diffuse involvement and 107 (94.7%) showed focal 
involvement. Nineteen of one hundred seven focal 
lesions (17.8%) were located in the skull base, and 
88 of them (82.2%) were found in the calvarium. 
Axial diameters of the lesions ranged from 3 to 50 
mm (mean, 14.09 mm). We observed concomitant 
parenchymal metastases in 12 lesions (10.6%). 
Thirty-four lesions (30.1%) had dural metastatic 
components, and 20 lesions (17.7%) were together 
with scalp metastases.  
 Table 1 summarizes the signal intensities of 
cranial bone marrow metastases. After intravenous 
contrast material administration, 101 lesions 
(89.4%) were enhanced, whereas 12 lesions were 
not enhanced on CE-FS T1WI. No MR image 
showed false-positive findings in the absence of 
pathologic findings. The sensitivities of DW-MRI 
and ADC for detecting cranial bone metastasis for 
all types of primary malignancies were 86% and 
90%, respectively.  The sensitivity of ADC for 
detecting cranial bone metastasis was superior to 
DW-MRI. The sensitivities of T1WI, FLAIR, CE-FS 
T1WI, and T2WI sequences for detecting cranial 
bone metastasis were 93%, 90%, 89%, and 84%, 
respectively. 
 The sensitivity of DW-MRI for detecting focal 
lesions was 90% and that for detecting diffuse 
lesions was 16.6%. The sensitivity of DW-MRI for 
detecting focal lesions was superior to that of DW- 
MRI for detecting diffuse lesions. The sensitivities 
of DW-MRI for detecting calvarial and skull base 
lesions were 89.7% and 94.7%, respectively. The 
sensitivity of DW-MRI for detecting cranial bone 
metastasis was 95% with scalp metastasis and 
84.9% without scalp metastasis.  
 The signal intensities of cranial bone marrow 
metastases on DW-MRI according to cancer type 
are shown in Table 2. The sensitivities of DW-MRI 
for detecting cranial bone metastasis of the lung, 
breast, and prostate cancers were 96.7%, 81.8%, 
and 72.7%, respectively. 
 Table 3 summarizes the comparison of DW-
MRI with conventional MRI in terms of the lesion 
conspicuousness of cranial bone marrow 
metastasis. Regarding lesion conspicuousness, 
DW-MRI was equivalent or superior to T1WI and 
FLAIR images in most of the lesions.  DW-MRI 
was superior to T2WI in lesion conspicuousness. 
DW-MRI was equivalent to CE-FS T1WI in most of 
the lesions (Figs. 1, 2 and 3). 
Lesion conspicuousness was not significantly 
different among all primary neoplasm types. When 
all of the sequences were compared, no significant 
difference in lesion conspicuousness was found 
according to lesion size, location, and diffuse or 
focal involvement. Interobserver correlation was 
used to evaluate agreement between the 
observers, and an excellent interobserver 
agreement was detected (80.0%). The 
intraobserver correlation was also excellent 
(κ=0.85).  
Table 1. Signal intensities of cranial bone marrow metastases  
Sequence Hypointense Hyperintense Isointense 
T1WI 105 (92.9%) 1 (0.9%) 7 (6.2%) 
T2WI 68 (60.2%) 28 (24.8%) 17 (15.0%) 
FLAIR 24 (21.2%) 78 (69.0%) 11 (9.7%) 
DW-MRI 9 (8%) 89 (78.8%) 15 (13.3%) 
ADC 95 (84.1%) 6 (5.3%) 12 (10.6%) 
Note. Diffusion-weighted MR imaging =DW-MRI, T1WI= T1-weighted images, T2WI= T2-weighted images, FLAIR= 
Fluid Attenuated Inversion Recovery, ADC= Apparent diffusion coefficient. 
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Table 2. Signal intensities of cranial bone marrow metastases on DW-MRI according to Cancer 
Type 
Cancer Type Hypointense Hyperintense Isointense 
Breast cancer 0 27 (81.8%) 6 (18.2%) 
Prostate cancer 5 (23.8%) 11 (52.4%) 5 (23.8%) 
Lung cancer 1 (3.2%) 29 (93.5%) 1 (3.2%) 
 
The others 3 (10.7%) 22(78.6%) 3 (10.7%) 
Note. Diffusion-weighted MR imaging=DW-MRI; the others= renal cell carcinoma, n=5; nasopharynx cancer, n=4; 
neuroblastoma, n=4; neuroendocrine tumor, n=3; adrenocortical carcinoma, n=3; cholangiocellular carcinoma, n=2; 
urinary bladder cancer, n=2; cervix cancer, n=1; ovarian cancer, n=1; thyroid cancer, n=1; primitive neuroectodermal 
tumor, n=1; squamous cell carcinoma of neck, n=1. 
Table 3. Comparison of DW-MRI and conventional MR examination in terms of the lesion 
conspicuousness of cranial bone marrow metastasis. 
 
Superior to DW-MRI Equivalent to DW-MRI Inferior to DW-MRI 
T1WI 10 (8.8%) 49 (43.4%) 54 (47.8%) 
T2WI 4 (3.5%) 
28 (24.8%) 
 81 (71.7%) 
FLAIR 10 (8.8%) 51 (45.1%) 52 (46.0%) 
CE T1WI 22 (19.5%) 61 (54.0%) 30 (26.5%) 
Note. Diffusion-weighted MR imaging =DW-MRI, T1WI= T1 weighted images, T2WI= T2 weighted images, FLAIR= Fluid 
Attenuated Inversion Recovery, CE T1WI= contrast enhanced T1 weighted images. 
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Figure 1.a-d. A 56-year-old woman with breast cancer. Axial T2- weighted (a), T1- weighted (b), diffusion-weighted MR 
images(c) and ADC map (d) show multiple cranial bone marrow metastases. The consciousness of the lesion is better 
on ADC map (arrows) than on other images.  
 
 
 
 
 
 
 Figure 2. a-d. A 43-year-old woman with lung cancer. Axial T1- weighted (a), fat-saturated contrast enhanced T1- 
weighted (b), diffusion-weighted MR images(c) and ADC map (d) show skull base metastases (arrow). Diffusion-
weighted MR images(c) and ADC map images superior to conventional MR images for the consciousness of the lesion. 
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Figure 3. a-d. A 61-year-old woman with lung cancer. Axial T1- weighted (a), fat-saturated contrast enhanced T1- 
weighted (b), diffusion-weighted MR images(c) and ADC map (d) show diffuse involvement of cranial bone marrow and 
parenchyma metastases(arrow).  
 
DISCUSSION 
 Our study showed that DW-MRI was 
equivalent to CE-FS T1WI and equivalent or 
superior to non-contrast conventional sequences 
for lesion conspicuousness in most of the cranial 
bone marrow metastases. Moon et al.
5
 showed 
that isotropic DW-MRI provided better lesion 
conspicuousness than T1WI or b0 images. T1WI 
had the highest sensitivity for detecting cranial 
bone marrow metastasis in our study. However, 
DW-MRI and other conventional MR sequences 
had similar sensitivity for detecting cranial bone 
marrow metastasis. The sensitivity of ADC for 
detecting cranial bone metastasis was superior to 
that of DW-MRI in our study. Therefore, ADC and 
DW-MRI can be used together to improve lesion 
detection and conspicuousness. Bone scintigraphy 
is a valuable screening test to detect bone marrow 
metastasis. However, it has low spatial resolution 
and specificity. Therefore, a combination of bone 
scintigraphy and other imaging methods is 
required for accurate diagnosis. MR sequences 
such as T1WI and CE-FS T1WI are valuable for 
the assessment of cranial bone marrow because 
they have high spatial resolution and tissue 
contrast. DW-MRI has been applied to vertebral 
bodies to differentiate between benign and 
malignant vertebral compression fractures
6
. 
Because DW-MRI with fat suppression is used; 
cranial bone marrow shows a hypointense signal 
on DW-MRI. Malignant infiltrations with enlarged 
nuclei, hypercellularity, and a reduced extracellular 
matrix generally produce reduced ADC values and 
result in increased signal intensity on DW-
MRI
7
.Normal cranial bone marrow is hypointense, 
and the lesions show hyperintense signals on DW-
MRI. This contrast can increase lesion detection 
and conspicuousness. Our results also reflect 
these changes.  
 We observed that DW-MRI had the highest 
sensitivity for detecting cranial bone marrow 
metastasis of lung cancer, whereas the sensitivity  
of DW-MRI for detecting cranial bone marrow 
metastasis of prostate cancer demonstrated the 
lowest value. Nemeth et al.
8
 showed that DW-MRI 
is a useful sequence for identifying focal skull 
metastases of breast and lung malignancies 
compared with conventional MRI. However, DW-
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MRI is insensitive for the detection of sclerotic skull 
metastases of prostate carcinoma. 
 We revealed that DW-MRI had higher 
sensitivity for detecting focal cranial bone marrow 
metastasis than for detecting diffuse metastasis. 
The sensitivity of DW-MRI for detecting focal 
lesions was 90% and that for detecting diffuse 
lesions was 16.6%. Our results are also consistent 
with the report by Nemeth et al.
8
 that DW-MRI 
provides improved detection of focal skull 
metastasis.  
 The sensitivities of DW-MRI for detecting 
calvarial and skull base lesions were 89.7% and 
94.7%, respectively. The skull base is a 
challenging region for imaging with DW-MRI due to 
its contents, such as air, bone, and fat. Thus, 
severe susceptibility artifacts can be evident, 
particularly near air-bone interfaces. Using a 
parallel imaging technique such as sensitivity 
encoding (SENSE) or generalized autocalibrating 
partially parallel acquisitions (GRAPPA) can 
markedly reduce magnetic susceptibility artifacts in 
the skull base, as was seen in our study. 
 The limitations of the present study must be 
acknowledged. First, the gold standard modality—
bone scintigraphy—was not used in the current 
study. Although bone scintigraphy is the standard 
method for the detection of bone metastases, no 
consensus exists that it is the best modality to 
diagnose bone metastases. Second, a relatively 
small number of cranial bone marrow metastases 
from each primary neoplasm were assessed in the 
present study. Additional studies with more 
homogeneous tumor groups may be required. We 
could not measure ADC values in the current 
study. Susceptibility artifacts are more pronounced 
within the bone, a find that can compromise correct 
ADC measurements. Thus, the authors decided 
not to obtain ADC measurements of the bone 
marrow. ADC measurements may be obtained 
from scalp metastases or the dural metastatic 
component of cranial bone marrow metastases in 
further studies. Malignant neoplasms have lower 
ADC values, whereas benign neoplasms have 
higher ADC values. The latter findings could be 
used to investigate the role of DW-MRI in 
differentiating between malignant and benign 
cranial bone marrow lesions. 
 In conclusion, DW-MRI is applied for the 
diagnosis of parenchymal metastasis, abscesses, 
and infarcts, in addition to routine conventional 
sequences in most radiology centers. When 
evaluating cranial bone marrow using DW-MRI and 
ADC maps, focusing not only on the diagnosis of 
parenchymal metastasis but also on cranial bone 
marrow metastasis can be helpful. Additionally, the 
assessment of DW-MRI and ADC maps together 
provides improved conspicuousness and detection 
of cranial bone marrow metastasis.  
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